Abstract
Clopidogrel (Plavix), a platelet aggregation inhibitor, has been shown to be effective in certain patients undergoing percutaneous coronary interventions, but its use in patients with acute myocardial infarction who receive a fibrinolytic strategy instead has been controversial. The aim of the Evidence-Based Medicine (EBM) Section is to bring the readership clinically relevant and practical evidence-based medicine principles and topic reviews. This EBM - Therapy review focuses on a relatively new therapy option for Emergency Department patients with acute myocardial infarction.
Original language | English (US) |
---|---|
Pages (from-to) | 479-483 |
Number of pages | 5 |
Journal | Journal of Emergency Medicine |
Volume | 34 |
Issue number | 4 |
DOIs | |
State | Published - May 2008 |
Keywords
- EBM
- clopidogrel
- drug therapy
- myocardial infarction
- platelet aggregation inhibitors
ASJC Scopus subject areas
- Emergency Medicine